GET A PIECE OF KETO5
Within 5 years, even if no additional sales are achieved other than those guaranteed by our experienced and substantial manufacturer and distributor as per the exclusive distribution agreement for weight loss, the company will gross a minimum of $18,500,000 revenue in 2027 with a projected 60%+ gross profit. This investment is in a company dedicated to the improvement of the health of its customers.
The global ketogenic diet market size was valued at $9.57 billion in 2019. And the ketogenic diet market is set to grow by USD 1.68 billion, progressing at a CAGR of over 5.5% between 2020 and 2025.*
Nearly 1.1M physicians practice in the US of which 381,000 are in the specialties and subspecialties that treat conditions for which Keto5 products are beneficial.**
Weight loss is not our end goal here. It’s your empowerment to live a high-quality, sustainable lifestyle with immense health benefits.
In the nearly 7 years since the formation of Keto5, founder Dr. Michael Wool, a renowned university research physician with a background in HIV antiviral drug therapy, and Stanley Ho, an engineer, brought together a small group of physicians to explore weight control using exogenous ketone supplementation.
A small clinical trial of 49 patients demonstrated weight loss averaging 10 pounds per month over eight weeks. During that time, it was noted that Keto5 patients with complicated medical diseases including diabetes, hypertension, asthma, and certain auto-immune diseases experienced additional improvement in their symptoms, laboratory measurement of inflammation, and reduction in standard of care prescription medications.
With this research, we learned that no matter your goals, Keto5 doctors will optimize your program for your personal physiology and objectives - helping you hit targets faster and more effectively.
*Our dietary ketone supplement has not been approved by the FDA nor do our products cure or treat any disease
In addition to weight loss, many patients may benefit from achieving durable increases of their ketosis levels when facing specific medical issues — such as diabetes, heart disease, autoimmune disorders, and even cancer — or to address a psychological challenge such as anxiety or depression.
We are all unique in our backgrounds and physical makeups. This type of tailored approach is the key to lasting metabolic results. We’re here to give the whole body treatment.
THE EVOLUTION OF THE HIGH CARB DIET
Our ancestors survived on fat stores (ketones) for days while hunting. And when they finally ate, it was mostly animal fat and protein. Human metabolism is still wired to work this way. Yet a carbohydrate-heavy diet has been foisted upon us for nearly 30 years, not to mention, billions in marketing by CPGs has driven average sugar consumption to 3 pounds per week (source).
Point blank: Living off of carbs and sugar now instead of fat is making us fat. So much so that 4 in 10 Americans are obese. Not just overweight, but obese. This obesity causes chronic inflammation everywhere in the body.
So while obesity-induced inflammation is busy making us sick… along comes a viral pandemic. Recent data from the CDC demonstrates that obesity increases the risk of severe illness from COVID-19. People who are overweight (but not obese) may also be at increased risk. Obese people may have triple the risk of hospitalization due to a COVID-19 infection (source).
Promoting the therapeutic power of high ketosis levels to the American public will help solve many health problems associated with obesity. That’s where we come in.
We’re seeing increasing popularity for the ketogenic diet (ancient man diet).
And with that, Keto5 will help thousands of overweight or obese people lose weight under the direction of a physician (by far the most effective of all weight loss programs) and reduce levels of inflammation and vulnerability to a host of inflammation-related diseases. It takes the ketogenic diet to the next (and more powerful level).
KETO5 is optimizing human health and longevity through 360-degree ketogenic management. We are cultivating a network of physicians that Keto5 will specially train in all aspects of ketogenic management, including metabolic function, inflammation physiology and immunology, as well as ketogenic nutrition and diet design.
Upon joining the Keto5 program, you can choose to partner with one of these highly knowledgeable and compassionate experts, or continue working with your own personal physician as part of your supervised keto care regimen.
Our flagship product, XOGENIUS, is a ketone salt supplement that produces nutritional ketosis in minutes vs. hours or days in a ketogenic diet alone.
XOGENIUS safely yields 200% - 500% higher ketone levels in 1 dose. We believe this is upwards of 6X the potency of other formulas available today (source). And Keto5 has exclusive rights to sell to a clinical network from the patent holder of the main ingredient of XO Immune and XO Genius.
XOGENIUS has helped patients achieve a median of 10 lbs. of weight loss and 81% reduced inflammation in just 30 days during proven clinical trials (source, source). Because of this efficacy, XOGENIUS even provides Nutritional Forgiveness. This means a flexible modern diet with some carbohydrates can be enjoyed while still maintaining adequate levels of ketosis.
Keto5 develops, manufactures, and will sell through a network of healthcare professionals its Keto5 products - all of which either contain exogenous ketone salts or related products to consume with the ketone salts-based products.
We'll sell Keto5 products initially through our clinical network that in turn sell to its patients. The company will also sell directly to consumers but only with the authorization of a network physician. They will be sold to health care professionals at a wholesale price that is more than double our cost of manufacturing. Our suite of exogenous salts products for mental sharpness, brain fog, esports, and other uses will be sold directly to consumers online with or without the authorization of a Keto5 clinical network healthcare provider.
But XOGENIUS doesn’t compete in the cluttered, low-margin, “snake oil” consumer market… Instead, we leverage a physician-only distribution network — initially targeting medical weight loss.
This growth is primarily in the ketogenic diet arena. However, there is increasing awareness among both health care professionals and consumers of the benefits of ketosis both from a weight loss perspective but also the many therapeutic benefits of being in a heightened state of ketosis.
The KETO5 network of healthcare professionals will prescribe custom individual tailored ketogenic subscription plans including laboratory monitoring, telemedicine remote monitoring, health coaching encouraging the best outcomes and sustained clinical benefits far beyond DIY consumer-grade, “over-the-counter” and “online” products.
Plus, Keto5’s products produce higher levels of ketosis (typically at least 5X) than those that are conventionally available in the "over the counter" marketplace, and up to 10 times higher than with a Keto diet alone.
*Images are computer generated demo versions. Product is still currently under development
The Keto5 proprietary formulations producing these optimized ketosis levels are best managed by Keto5’s experts to achieve optimized patient results. Due to ubiquitous ketogenic diets along with the advancing patient population using exogenous ketones, questions about their use logically defaults to the primary care physician. Only a minority of physicians can adequately answer patient questions and give appropriate guidance about "Targeted Ketosis".
Here’s a closer look at what we’ve been up to, and where we are headed:
Keto5 will help this experienced and substantial manufacturer and distributor increase its medical network for weight loss by co-marketing with them. Dr. Wool will be meeting with many large medical weight loss centers including IdealProtein, Metabolic, Ranier, Moxy, Lindora and others to persuade them of the benefits of products containing GoBHB for weight loss.
We believe that with a clinical network of only 1,000 health care professionals, apart from the experienced and substantial manufacturer and distributor’s existing network (out of a target range of 1,100,000 primary care and specialist physicians) could help us reach our goal of becoming a $400 Million company. The value of the clinical network alone will be extremely valuable.
*The above testimonials may not be representative of the opinions of other medical experts or experiences of other customers and is not a guarantee of future performance or success.
Professional and consumer awareness of the powerful therapeutic benefits of high ketone levels in humans is in its infancy. Although the term “keto” has crept into the public vernacular over the past 5 years, the enormous range of benefits of ketosis is barely understood by the population at large.
We are truly at the dawn of a new age where the power of ketones is about to be unlocked and unleashed. If this thesis is proven to be correct, then, given the company’s exclusive rights in the clinical network, we believe the potential for growth is enormous.
THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
At Keto5, we’re on a mission to improve the quality of life for everyone. Our products dramatically increase ketone levels in the bloodstream, enabling users to achieve at least 5 times the level of ketosis achieved by diet alone. Keto5 is building a nationwide and international network of medical care professionals who will sell the products to their patients and supervise their use of the products. We are a pre-market, pre-revenue company with strategic hardware partnerships in place. We will commence building our clinical network in late Q2 of 2022.
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
First 30 days, receive 5% bonus shares
Tier 1 Perk — Invest $5,000+ and receive 3% bonus shares
Tier 2 Perk — Invest $10,000+ and receive 19% bonus shares
Tier 3 Perk — Invest $25,000+ and receive 25% bonus shares
Tier 4 Perk — Invest $50,000+ and receive 30% bonus shares
Tier 5 Perk — Invest $75,000+ and receive 35% bonus shares
Tier 6 Perk — Invest $100,000+ and receive 40% bonus shares
*All perks occur when the offering is completed.
Keto5, Inc will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Class B at $5.00 / share, you will receive 110 shares of Common Class B, meaning you'll own 110 shares for $500. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company will not incur any irregular use of proceeds.
Members get an extra 10% shares in addition to rewards below!
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.